Name:
TheimpactofHSV.doc
Size:
33.5Kb
Format:
Microsoft Word
Description:
Author's Final Peer-Reviewed Copy
Affiliation
Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. mortimeroconnor@gmail.comIssue Date
2012-02MeSH
Antirheumatic AgentsArthritis
Herpes Labialis
Herpesvirus 1, Human
Humans
Immunocompromised Host
Immunosuppressive Agents
Inflammation
Metadata
Show full item recordCitation
The impact of HSV for inflammatory arthropathy patients. 2012, 32 (2):489-90 Rheumatol. Int.Journal
Rheumatology internationalDOI
10.1007/s00296-010-1758-xPubMed ID
21243495Abstract
Herpes simplex virus type 1 (HSV-1), also known as herpes labialis, is the etiologic agent of vesicular lesions of the oral mucosa commonly referred to as "cold sores". HSV-1 can also cause clinical disease in a wide variety of other anatomic locations including the genitalia, liver, lung, eye, and central nervous system. These infections can be severe, particularly in the setting of immunosuppression, such as inflammatory arthropathy patients on Methotrexate ± biological therapies. Here, we highlight the importance of physician awareness of HSV due to its potential impact for rheumatology patients.Item Type
ArticleLanguage
enISSN
1437-160Xae974a485f413a2113503eed53cd6c53
10.1007/s00296-010-1758-x
Scopus Count
Collections
Related articles
- Herpes simplex type-1 virus infection.
- Authors: Huber MA
- Issue date: 2003 Jun
- Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4.
- Authors: Lin WR, Shang D, Wilcock GK, Itzhaki RF
- Issue date: 1995 Nov
- Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
- Authors: Arduino PG, Porter SR
- Issue date: 2008 Feb
- Natural history, management and complications of herpes labialis.
- Authors: Higgins CR, Schofield JK, Tatnall FM, Leigh IM
- Issue date: 1993
- Herpes simplex virus infection: part I--Biology, clinical presentation and latency.
- Authors: Yarom N, Buchner A, Dayan D
- Issue date: 2005 Jan